Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

The complement cascade in kidney disease: from sideline to center stage.

McCaughan JA, O'Rourke DM, Courtney AE.

Am J Kidney Dis. 2013 Sep;62(3):604-14. doi: 10.1053/j.ajkd.2012.12.033. Epub 2013 Mar 13. Review.

PMID:
23489674
2.

[The complement system--structure, activation, regulation and function].

Bjørge L.

Tidsskr Nor Laegeforen. 1999 Jan 20;119(2):226-33. Review. Norwegian.

PMID:
10081355
3.

Kidney diseases caused by complement dysregulation: acquired, inherited, and still more to come.

Heeringa SF, Cohen CD.

Clin Dev Immunol. 2012;2012:695131. doi: 10.1155/2012/695131. Epub 2012 Nov 14. Review.

4.

The complement system. Activation, modulation, and clinical relevance.

Lim HW.

Dermatol Clin. 1990 Oct;8(4):609-18. Review.

PMID:
2249355
5.

Molecules Great and Small: The Complement System.

Mathern DR, Heeger PS.

Clin J Am Soc Nephrol. 2015 Sep 4;10(9):1636-50. doi: 10.2215/CJN.06230614. Epub 2015 Jan 7. Review.

6.

Functional assessment of rat complement pathway activities and quantification of soluble C5b-9 in an experimental model of renal ischemia/reperfusion injury.

Kotimaa J, van der Pol P, Leijtens S, Klar-Mohammad N, Schilders G, Daha MR, Rutjes H, van Kooten C.

J Immunol Methods. 2014 Oct;412:14-23. doi: 10.1016/j.jim.2014.06.011. Epub 2014 Jun 19.

PMID:
24953215
7.

Complement in transplant rejection: diagnostic and mechanistic considerations.

Baldwin WM, Ota H, Rodriguez ER.

Springer Semin Immunopathol. 2003 Sep;25(2):181-97. Review.

PMID:
12955466
8.

Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage.

Castellano G, Melchiorre R, Loverre A, Ditonno P, Montinaro V, Rossini M, Divella C, Battaglia M, Lucarelli G, Annunziata G, Palazzo S, Selvaggi FP, Staffieri F, Crovace A, Daha MR, Mannesse M, van Wetering S, Paolo Schena F, Grandaliano G.

Am J Pathol. 2010 Apr;176(4):1648-59. doi: 10.2353/ajpath.2010.090276. Epub 2010 Feb 11.

9.

Biology of complement: the overture.

Kinoshita T.

Immunol Today. 1991 Sep;12(9):291-5. Review. No abstract available.

PMID:
1755940
10.

Detection of complement in relation to disease.

Frank MM.

J Allergy Clin Immunol. 1992 Mar;89(3):641-8.

PMID:
1545085
11.

[Analysis serum complement activity in infants during their first year of life].

Grigorek Kh, Imel'ska D, Madalin'ski K, Sabboikh K, Van'ko LV, Sukhikh GT.

Akush Ginekol (Mosk). 1990 Jan;(1):38-40. Russian. No abstract available.

PMID:
2353731
12.

The complement cascade and renal disease.

Kościelska-Kasprzak K, Bartoszek D, Myszka M, Zabińska M, Klinger M.

Arch Immunol Ther Exp (Warsz). 2014 Feb;62(1):47-57. doi: 10.1007/s00005-013-0254-x. Epub 2013 Sep 13. Review.

13.

Complement depletion in rats infected with Fasciola hepatica: in vivo and in vitro studies.

Baeza E, Poitou I, Villejoubert C, Boulard C.

Vet Parasitol. 1994 Feb;51(3-4):219-30.

PMID:
8171824
14.

Complement cascade in systemic lupus erythematosus: analyses of the three activation pathways.

Ceribelli A, Andreoli L, Cavazzana I, Franceschini F, Radice A, Rimoldi L, Sinico RA, Carlsson M, Wieslander J, Tincani A.

Ann N Y Acad Sci. 2009 Sep;1173:427-34. doi: 10.1111/j.1749-6632.2009.04921.x.

PMID:
19758182
15.

The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation.

Harboe M, Ulvund G, Vien L, Fung M, Mollnes TE.

Clin Exp Immunol. 2004 Dec;138(3):439-46.

16.

Properdin in complement activation and tissue injury.

Lesher AM, Nilsson B, Song WC.

Mol Immunol. 2013 Dec 15;56(3):191-8. doi: 10.1016/j.molimm.2013.06.002. Epub 2013 Jun 29. Review.

17.

Complement and kidney disease.

Cook HT.

Curr Opin Nephrol Hypertens. 2013 May;22(3):295-301. doi: 10.1097/MNH.0b013e32835ff9cb. Review.

PMID:
23508058
18.

New concepts of complement in allorecognition and graft rejection.

Wasowska BA, Lee CY, Halushka MK, Baldwin WM 3rd.

Cell Immunol. 2007 Jul;248(1):18-30. Epub 2007 Oct 24. Review.

19.

The dual role of complement in the progression of renal disease in NZB/W F(1) mice and alternative pathway inhibition.

Sekine H, Ruiz P, Gilkeson GS, Tomlinson S.

Mol Immunol. 2011 Oct;49(1-2):317-23. doi: 10.1016/j.molimm.2011.09.015. Epub 2011 Oct 14.

PMID:
22000720
20.

Autoantibodies against complement components and functional consequences.

Dragon-Durey MA, Blanc C, Marinozzi MC, van Schaarenburg RA, Trouw LA.

Mol Immunol. 2013 Dec 15;56(3):213-21. doi: 10.1016/j.molimm.2013.05.009. Epub 2013 Jun 20. Review.

PMID:
23790637

Supplemental Content

Support Center